Shockwave Medical (SWAV) Tops Q1 EPS by 23c; Guides Higher

Shockwave Medical (NASDAQ: SWAV) reported Q1 EPS of $0.41, $0.23 better than the analyst estimate of $0.18. Revenue for the quarter came in at $93.6 million versus the consensus estimate of $86.41 million.

GUIDANCE:

Shockwave Medical sees Q2 2022 revenue of $435-455 million, versus the consensus of $417.9 million.

For earnings history and earnings-related data on Shockwave Medical (SWAV) click here.

You May Also Be Interested In

• Stran & Company, Inc. (SWAG) Reports Q2 EPS of $0.02
• CI&T Inc (CINT) Misses Q2 EPS by 3c
• Integra Resources (ITRG) Tops Q2 EPS by 6c